Skip to content

Study · Measured the body's own peptide · 2019

1 result

Comparative proteomic analysis of plasma of children with congenital heart disease.

Huang Q, Geng Z, Chen T, Cheng X, Gu H, Li Q, Li D, Liu R

Electrophoresis14 May 2019Cited by 3 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In children with ventricular septal defect, the ROC area under the curve of plasma Tβ4, together with ALDOB, was higher than that of other candidate proteins.

    In plain wordsIn children with a heart defect, the body's own thymosin beta‑4 in blood may help identify the defect.

    Outcome
    Direction not reportedPlasma Tβ4 as biomarker for ventricular septal defect (ROC AUC)
    Study

    n: not reported in source

    Outcome group
    Cardiovascular events · Cardiovascular

    Source sentences

    Summary
    The areas under the receiver operating characteristic curve values of fructose-bisphosphate aldolase B (ALDOB) and thymosin beta-4 (Tβ4) were higher than those of other candidate proteins.
    3 context sentences
    Summary · context
    ALDOB and Tβ4 might be potential biomarkers applied for identifying VSD in the further works.
    Summary · context
    Eight subjects with ventricular septal defect (VSD, a kind of congenital heart disease) and 11 health children were enrolled in tandem mass tags label-based quantitative proteomic analysis to compare plasma proteins differentially abundance.
    Summary · context
    The amount of ten proteins changed significantly (p < 0.05) in newly recruited 30 VSD compared with 15 control children, which were validated by ELISA.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.